Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-02

Clinical Trial Update: Evaluation of Efficacy and Safety of Alcarisa (Hyaluronic Acid Produced by Espad Pharmed Co.) for Restoration of Mid-face Volume [NA]

View source ↗

Summary

A clinical trial evaluating the efficacy and safety of Alcarisa, a hyaluronic acid product produced by Espad Pharmed Co., for restoration of mid-face volume, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alcarisa (Hyaluronic acid)

Snippet

Sponsor: Espad Pharmed | Conditions: Mid Face Volume Deficit | NA | Status: RECRUITING